Episode 81

#81: Our Take, November 11, 2019

Nov 11, 2019

9:49

Medical Devices Pharma & Biotech

Episode Description

Other briefs include:

Stryker signed a definitive agreement to acquire Wright Medical Group.
Amgen will pay $2.7 billion for a 20.5% ownership stake in BeiGene, a research-based, oncology-focused biotech company headquartered in Beijing.
The University of Louisville announced that it has completed the acquisition of KentuckyOne Health’s Louisville-area assets from CommonSpirit Health.
HealthPartners is closing its mail order and all 30 retail pharmacy locations, and will lay off 300 workers.
Dr. Philip Ozuah will become Montefiore Medicine’s new CEO.
Dr. Stephen Hahn has been nominated as the FDA’s new commissioner.
Several updates from CMS.

About Darwin Research Group

Darwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin’s client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.

CONNECT WITH US:
🌐 Visit us on the web
🌐 Follow Health Care Rounds on LinkedIn
🌐 Follow Darwin Research Group on LinkedIn

📺 Watch Health Care Rounds on YouTube
🎧 Listen on Apple Podcasts
🎧 Listen on Spotify

⚙️ Health Care Rounds is produced by Grippi Media